GGrantIndex
Sort

46,585 grants matching heart failure

Columbia University and Northern Plains Partnership for the Superfund Research Program

$1,925,287
Ana Navas-Acien · Columbia University Health Sciences · P42 · FY2023 · ES

DNA virus as vectors for cardiovascular diseases

$1,925,010
James M Wilson · University Of Pennsylvania · P01 · FY2006 · HL

Late-life trajectories of cardiac function to define pathways of cardiac resilience

$1,924,088
Amil M Shah · Ut Southwestern Medical Center · R01 · FY2025 · HL

Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization

$1,923,922
Salwa A Elgebaly · Nour Heart, Inc. · R44 · FY2025 · HL

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,923,520
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA

Stem Cell and Cardiac Aging

$1,922,579
Piero Anversa · New York Medical College · P01 · FY2006 · AG

Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias

$1,921,353
Courtney Fitzhugh · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

NCRM Pilot Grant Funding

$1,921,000
John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2010 · AR

DNA virus as vectors for cardiovascular diseases

$1,920,797
University Of Pennsylvania · P01 · FY2005 · HL

Neurohumoral Adaptations to Chronic Intermittent Hypoxia: Insights into the Pathophysiology of Sleep Apnea

$1,920,384
Steven W. Mifflin · University Of North Texas Hlth Sci Ctr · P01 · FY2015 · HL

Role of O-glycosylation in Animal Development

$1,918,999
Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE

DNA virus as vectors for cardiovascular diseases

$1,918,557
James M Wilson · University Of Pennsylvania · P01 · FY2007 · HL

INTERDISCIPLINARY STUDY OF DELIRIUM AND ITS LONG-TERM OUTCOMES

$1,917,539
Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2013 · AG

Biology and Novel Therapeutics of Cardiovascular Peptides

$1,916,871
John C Burnett · Mayo Clinic Rochester · P01 · FY2012 · HL

Myocardial Hypertrophy and Heart Failure

$1,915,861
Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2007 · HL

Protecting Myocardium by Enhancing Mitochodrial Integrity

$1,915,794
Mark Alan Sussman · San Diego State University · P01 · FY2006 · HL

The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)

$1,911,200
Judith S Hochman · New York University School Of Medicine · R01 · FY2023 · HL

Structual Genomics of Norepinephrine Transporters

$1,908,053
Vanderbilt University · P01 · FY2004 · HL

Neuro-Circulatory Function in Chronic Heart Failure

$1,906,385
Irving H Zucker · University Of Nebraska Medical Center · P01 · FY2011 · HL

Gene Therapy for Lung and Cardiovascular Disease

$1,906,199
University Of Florida · P01 · FY2002 · HL

Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry

$1,904,162
Ray E Hershberger · Ohio State University · R01 · FY2020 · HL

Autonomic Cardiovascular Regulation

$1,903,487
David Herlie Robertson · Vanderbilt University · P01 · FY2015 · HL

Integrated Mechanisms of Cardiac Maladaptation

$1,902,918
R John Solaro · University Of Illinois At Chicago · P01 · FY2017 · HL

Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias

$1,902,764
Courtney Fitzhugh · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

1/2 – Pediatric Prehospital Airway Resuscitation Trial

$1,902,731
Henry E Wang · Ohio State University · UG3 · FY2023 · HL